Sagility India Ltd
Incorporated in July 2021, Sagility India Limited (formerly Berkmeer India Pvt. Ltd) provides healthcare-focused technology-enabled solutions and services primarily to U.S.-based clients in the payer and provider segments.[1]
- Market Cap ₹ 21,146 Cr.
- Current Price ₹ 45.2
- High / Low ₹ 46.1 / 27.0
- Stock P/E 92.9
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 4.71 %
- ROE 3.60 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Debtor days have improved from 183 to 90.7 days.
- Company's working capital requirements have reduced from 55.0 days to 24.5 days
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 8m | Mar 2023 | Mar 2024 | |
|---|---|---|---|
| 923 | 4,218 | 4,754 | |
| 730 | 3,179 | 3,665 | |
| Operating Profit | 193 | 1,039 | 1,088 |
| OPM % | 21% | 25% | 23% |
| 18 | 5 | 28 | |
| Interest | 65 | 215 | 185 |
| Depreciation | 147 | 644 | 689 |
| Profit before tax | -2 | 186 | 242 |
| Tax % | 152% | 23% | 6% |
| -5 | 144 | 228 | |
| EPS in Rs | -0.02 | 0.75 | 0.53 |
| Dividend Payout % | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 54% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 4% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|
| Equity Capital | 1,919 | 1,919 | 4,285 | 4,679 |
| Reserves | 2,108 | 4,288 | 2,158 | 3,137 |
| 4,788 | 2,896 | 2,532 | 1,498 | |
| 1,271 | 1,427 | 1,554 | 1,316 | |
| Total Liabilities | 10,085 | 10,529 | 10,529 | 10,630 |
| 8,621 | 8,607 | 8,667 | 8,557 | |
| CWIP | 5 | 0 | 6 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| 1,459 | 1,922 | 1,856 | 2,074 | |
| Total Assets | 10,085 | 10,529 | 10,529 | 10,630 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|
| -32 | 857 | 973 | |
| -7,711 | -101 | -463 | |
| 8,116 | -545 | -751 | |
| Net Cash Flow | 374 | 211 | -241 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|
| Debtor Days | 366 | 92 | 91 |
| Inventory Days | |||
| Days Payable | |||
| Cash Conversion Cycle | 366 | 92 | 91 |
| Working Capital Days | 115 | 25 | 25 |
| ROCE % | 5% | 5% |
Documents
Announcements
-
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
1d - Disclosure of share encumbrance by Sagility B.V.
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 17 Dec
- Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011. 13 Dec
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 13 Dec
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 11 Dec
Concalls
-
Nov 2024Transcript PPT REC
Market Share [1] Headquartered in Bangalore, the company serves only US customers. It holds 1.23% of the U.S. healthcare outsourcing market as of 2023.
Client Segmentation[2]
- Payers: Health insurance companies that finance and reimburse healthcare services. Sagility provides them with services like claims processing, payment integrity, and clinical management.
- Providers: Hospitals, physicians, and diagnostic centers, with services focused on revenue cycle management (RCM) that includes insurance verification, billing, and accounts receivable follow-up.